Elicio Therapeutics (ELTX) Other Non Operating Income (2020 - 2026)

Elicio Therapeutics (ELTX) has 6 years of Other Non Operating Income data on file, last reported at $13000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at $13000.0 (up 750.0% YoY), and the FY2024 full-year result was $151000.0, down 64.8% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $13000.0, up from $8000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $492000.0 in Q2 2023 and bottomed at -$945000.0 in Q4 2022.
• The 4-year median for Other Non Operating Income is $8000.0 (2024), against an average of -$19454.5.
• The widest annual swing landed in 2022, when Other Non Operating Income slumped 404.55%; it then soared 543.24% in 2023.
• A 4-year view of Other Non Operating Income shows it stood at -$945000.0 in 2022, then surged by 96.51% to -$33000.0 in 2023, then soared by 124.24% to $8000.0 in 2024, then surged by 62.5% to $13000.0 in 2026.
• The last three Other Non Operating Income figures came in at $13000.0 (Q1 2026), $8000.0 (Q4 2024), and -$1000.0 (Q3 2024), per Business Quant data.

Peer Comparison